Exploring Prolonged Efficacy of Ferumoxytol‐Enhanced Whole‐Body MR Angiography: A Preliminary Study in Healthy Male Subjects
- 16 July 2024
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 61 (3) , 1515-1518
Abstract
No abstract availableFunding Information
- Jiangsu Commission of Health (M2022066)
- Natural Science Foundation of Jiangsu Province (BK20222002)
- National Natural Science Foundation of China (51832001, 61821002, 82272065, 62394312)
This publication has 9 references indexed in Scilit:
- Diagnostic Performance and Safety of a Novel Ferumoxytol-Enhanced Coronary Magnetic Resonance AngiographyCirculation: Cardiovascular Imaging, 2023
- Preoperative evaluation and perioperative management of patients undergoing major vascular surgeryVascular Medicine, 2022
- A contemporary understanding of iron metabolism in active premenopausal femalesFrontiers in Sports and Active Living, 2022
- Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRIRadiology, 2019
- Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney diseaseEuropean Radiology, 2019
- Whole-body magnetic resonance angiographyClinical Radiology, 2018
- Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR‐angiography at 3.0 tesla: Effects of contrast bolus length and flip angleJournal of Magnetic Resonance Imaging, 2016
- High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohortPediatric Nephrology, 2014
- Ionising radiation-free whole-body MRI versus 18F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre studyThe Lancet Oncology, 2014